A Curated Platform of Equity & Options Market Intelligence
Select Page

NTLA

Search by
TICKER SYMBOL

Intellia Therapeutics Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

27.51

0.49

(1.813%)

Volume:

0

52 week range:

22.67 - 47.48

Market Cap:

2.644B

Company Description:

intellia therapeutic’s core mission is to develop curative medicines, utilizing the promise of the crispr/cas9 gene editing technology. the development of crispr/cas9 gene editing technology opens a new frontier in biomedical research and clinical intervention. adapted from a natural cellular process, crispr/cas9 permits the editing of any gene in any organism with unprecedented simplicity and flexibility. the incredible potential of this technology for treating human genetic disease inspired a group of life science veterans to create intellia therapeutics. intellia was founded in 2014 by caribou biosciences and atlas venture, along with a consortium of scientists who have helped define the space. intellia therapeutics holds exclusive access to a broad intellectual property portfolio covering the application of crispr/cas9 technology for human therapeutic use. intellia has built an experienced team of individuals to meet the challenges of bringing crispr/cas9 therapeutics to the